RG
JNCE
Redmile Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-254,590
| Closed | -$1.26M | – | 85 |
|
|
2019
Q2 | $1.26M | Hold |
254,590
| – | – | 0.04% | 67 |
|
|
2019
Q1 | $1.58M | Sell |
254,590
-1,883
| -0.7% | -$11.7K | 0.05% | 66 |
|
|
2018
Q4 | $864K | Sell |
256,473
-168,942
| -40% | -$569K | 0.03% | 64 |
|
|
2018
Q3 | $2.77M | Sell |
425,415
-789,178
| -65% | -$5.13M | 0.09% | 66 |
|
|
2018
Q2 | $9.3M | Buy |
1,214,593
+32,200
| +3% | +$247K | 0.32% | 52 |
|
|
2018
Q1 | $26.4M | Buy |
1,182,393
+202,000
| +21% | +$4.51M | 1.02% | 31 |
|
|
2017
Q4 | $12.5M | Buy |
980,393
+24,795
| +3% | +$316K | 0.54% | 50 |
|
|
2017
Q3 | $14.9M | Sell |
955,598
-182,772
| -16% | -$2.85M | 0.73% | 39 |
|
|
2017
Q2 | $16M | Buy |
1,138,370
+24,210
| +2% | +$340K | 0.97% | 38 |
|
|
2017
Q1 | $22.5M | Buy |
+1,114,160
| New | +$22.5M | 1.46% | 26 |
|